The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023)

Background: The COVID-19 pandemic disrupted routine child immunization efforts, threatening to reverse progress in controlling vaccine-preventable diseases. Materials and Methods: We analyzed the impact of COVID-19 on DTP3 vaccination in Europe by comparing trends before and after the pandemic using...

Full description

Saved in:
Bibliographic Details
Main Authors: Ines Aguinaga-Ontoso, Sara Guillen-Aguinaga, Laura Guillen-Aguinaga, Rosa Alas-Brun, Miriam Guillen-Aguinaga, Luc Onambele, Enrique Aguinaga-Ontoso, Esperanza Rayón-Valpuesta, Francisco Guillen-Grima
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/13/1/6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587355588919296
author Ines Aguinaga-Ontoso
Sara Guillen-Aguinaga
Laura Guillen-Aguinaga
Rosa Alas-Brun
Miriam Guillen-Aguinaga
Luc Onambele
Enrique Aguinaga-Ontoso
Esperanza Rayón-Valpuesta
Francisco Guillen-Grima
author_facet Ines Aguinaga-Ontoso
Sara Guillen-Aguinaga
Laura Guillen-Aguinaga
Rosa Alas-Brun
Miriam Guillen-Aguinaga
Luc Onambele
Enrique Aguinaga-Ontoso
Esperanza Rayón-Valpuesta
Francisco Guillen-Grima
author_sort Ines Aguinaga-Ontoso
collection DOAJ
description Background: The COVID-19 pandemic disrupted routine child immunization efforts, threatening to reverse progress in controlling vaccine-preventable diseases. Materials and Methods: We analyzed the impact of COVID-19 on DTP3 vaccination in Europe by comparing trends before and after the pandemic using time series data from 2000 to 2023. Employing joinpoint regression, chi-square tests, and segmented regression analysis, we assessed DTP3 vaccination trends and coverage changes. Results: The findings revealed significant regional disparities across Europe. Statistical models indicated reductions in DTP3 coverage in countries such as Ireland, Sweden, and Switzerland, whereas Ukraine and San Marino showed improvements. Conclusions: There are variations in the effect of COVID-19 on DTP3 coverage rates, indicating the need for targeted public health strategies to address vaccine hesitancy, logistical barriers, and systemic inequities.
format Article
id doaj-art-5f1e0070728b4cd6b82de28014063422
institution Kabale University
issn 2076-393X
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj-art-5f1e0070728b4cd6b82de280140634222025-01-24T13:51:38ZengMDPI AGVaccines2076-393X2024-12-01131610.3390/vaccines13010006The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023)Ines Aguinaga-Ontoso0Sara Guillen-Aguinaga1Laura Guillen-Aguinaga2Rosa Alas-Brun3Miriam Guillen-Aguinaga4Luc Onambele5Enrique Aguinaga-Ontoso6Esperanza Rayón-Valpuesta7Francisco Guillen-Grima8Department of Health Sciences, Public University of Navarra, 31008 Pamplona, SpainDepartment of Health Sciences, Public University of Navarra, 31008 Pamplona, SpainDepartment of Nursing, Kystad Helse-og Velferdssenter, 7026 Trondheim, NorwayDepartment of Health Sciences, Public University of Navarra, 31008 Pamplona, SpainNeoma Business School, 75013 Paris, FranceSchool of Health Sciences, Catholic University of Central Africa, Yaoundé 1110, CameroonDepartment of Sociosanitary Sciences, University of Murcia, 30003 Murcia, SpainDepartment of Nursing, Complutense University of Madrid, 28040 Madrid, SpainDepartment of Health Sciences, Public University of Navarra, 31008 Pamplona, SpainBackground: The COVID-19 pandemic disrupted routine child immunization efforts, threatening to reverse progress in controlling vaccine-preventable diseases. Materials and Methods: We analyzed the impact of COVID-19 on DTP3 vaccination in Europe by comparing trends before and after the pandemic using time series data from 2000 to 2023. Employing joinpoint regression, chi-square tests, and segmented regression analysis, we assessed DTP3 vaccination trends and coverage changes. Results: The findings revealed significant regional disparities across Europe. Statistical models indicated reductions in DTP3 coverage in countries such as Ireland, Sweden, and Switzerland, whereas Ukraine and San Marino showed improvements. Conclusions: There are variations in the effect of COVID-19 on DTP3 coverage rates, indicating the need for targeted public health strategies to address vaccine hesitancy, logistical barriers, and systemic inequities.https://www.mdpi.com/2076-393X/13/1/6DTP3 vaccinationCOVID-19 pandemic impactvaccination trendsEurope
spellingShingle Ines Aguinaga-Ontoso
Sara Guillen-Aguinaga
Laura Guillen-Aguinaga
Rosa Alas-Brun
Miriam Guillen-Aguinaga
Luc Onambele
Enrique Aguinaga-Ontoso
Esperanza Rayón-Valpuesta
Francisco Guillen-Grima
The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023)
Vaccines
DTP3 vaccination
COVID-19 pandemic impact
vaccination trends
Europe
title The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023)
title_full The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023)
title_fullStr The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023)
title_full_unstemmed The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023)
title_short The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023)
title_sort impact of covid 19 on dtp3 vaccination coverage in europe 2012 2023
topic DTP3 vaccination
COVID-19 pandemic impact
vaccination trends
Europe
url https://www.mdpi.com/2076-393X/13/1/6
work_keys_str_mv AT inesaguinagaontoso theimpactofcovid19ondtp3vaccinationcoverageineurope20122023
AT saraguillenaguinaga theimpactofcovid19ondtp3vaccinationcoverageineurope20122023
AT lauraguillenaguinaga theimpactofcovid19ondtp3vaccinationcoverageineurope20122023
AT rosaalasbrun theimpactofcovid19ondtp3vaccinationcoverageineurope20122023
AT miriamguillenaguinaga theimpactofcovid19ondtp3vaccinationcoverageineurope20122023
AT luconambele theimpactofcovid19ondtp3vaccinationcoverageineurope20122023
AT enriqueaguinagaontoso theimpactofcovid19ondtp3vaccinationcoverageineurope20122023
AT esperanzarayonvalpuesta theimpactofcovid19ondtp3vaccinationcoverageineurope20122023
AT franciscoguillengrima theimpactofcovid19ondtp3vaccinationcoverageineurope20122023
AT inesaguinagaontoso impactofcovid19ondtp3vaccinationcoverageineurope20122023
AT saraguillenaguinaga impactofcovid19ondtp3vaccinationcoverageineurope20122023
AT lauraguillenaguinaga impactofcovid19ondtp3vaccinationcoverageineurope20122023
AT rosaalasbrun impactofcovid19ondtp3vaccinationcoverageineurope20122023
AT miriamguillenaguinaga impactofcovid19ondtp3vaccinationcoverageineurope20122023
AT luconambele impactofcovid19ondtp3vaccinationcoverageineurope20122023
AT enriqueaguinagaontoso impactofcovid19ondtp3vaccinationcoverageineurope20122023
AT esperanzarayonvalpuesta impactofcovid19ondtp3vaccinationcoverageineurope20122023
AT franciscoguillengrima impactofcovid19ondtp3vaccinationcoverageineurope20122023